PL326080A1 - Short forms of chemokin beta-8 - Google Patents

Short forms of chemokin beta-8

Info

Publication number
PL326080A1
PL326080A1 PL96326080A PL32608096A PL326080A1 PL 326080 A1 PL326080 A1 PL 326080A1 PL 96326080 A PL96326080 A PL 96326080A PL 32608096 A PL32608096 A PL 32608096A PL 326080 A1 PL326080 A1 PL 326080A1
Authority
PL
Poland
Prior art keywords
chemokin
beta
short forms
short
forms
Prior art date
Application number
PL96326080A
Inventor
John White
Edward Appelbaum
Daniel O'shannessy
James Allan Fornwald
Kevin O'donnell
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PL326080A1 publication Critical patent/PL326080A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL96326080A 1995-09-29 1996-09-27 Short forms of chemokin beta-8 PL326080A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US451795P 1995-09-29 1995-09-29
PCT/US1996/015592 WO1997012041A1 (en) 1995-09-29 1996-09-27 SHORT FORMS OF CHEMOKINE β-8

Publications (1)

Publication Number Publication Date
PL326080A1 true PL326080A1 (en) 1998-08-17

Family

ID=21711157

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96326080A PL326080A1 (en) 1995-09-29 1996-09-27 Short forms of chemokin beta-8

Country Status (16)

Country Link
EP (1) EP0859842A4 (en)
JP (1) JPH11512610A (en)
KR (2) KR20030096447A (en)
CN (2) CN1198186A (en)
AU (1) AU711573B2 (en)
BG (1) BG102413A (en)
BR (1) BR9610671A (en)
CZ (1) CZ92198A3 (en)
EA (1) EA199800352A1 (en)
HU (1) HUP9802699A3 (en)
NO (1) NO981387L (en)
NZ (1) NZ320932A (en)
PL (1) PL326080A1 (en)
TR (1) TR199800575T1 (en)
WO (1) WO1997012041A1 (en)
ZA (1) ZA968204B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488925B2 (en) 1993-12-22 2002-12-03 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polypeptides
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US6001606A (en) * 1994-03-08 1999-12-14 Human Genome Sciences, Inc. Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby
US6451562B1 (en) 1993-12-22 2002-09-17 Human Genome Sciences, Inc. Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides
US6495129B1 (en) 1994-03-08 2002-12-17 Human Genome Sciences, Inc. Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
NZ335003A (en) * 1996-09-30 2000-11-24 Human Genome Sciences Inc Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1)
KR19990042713A (en) * 1997-11-27 1999-06-15 허일섭 Method for preparing CDNA and recombinant LKN-1 of C 6 beta-chemokine LKN-1 isolated from human
AU2505601A (en) * 1999-11-15 2001-05-30 Wolf-Georg Forssmann Novel use of hcc-2
US20030215460A1 (en) * 2002-05-07 2003-11-20 Schall Thomas J. Methods and compositions for inducing an immune response

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017092A1 (en) * 1993-12-22 1995-06-29 Human Genome Sciences, Inc. MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1¿η?
CN1125082C (en) * 1995-05-05 2003-10-22 人类基因组科学公司 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
JP2001519757A (en) * 1995-10-24 2001-10-23 スミスクライン・ビーチャム・コーポレイション Novel chemokines for stem cell mobilization
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10

Also Published As

Publication number Publication date
CN1405180A (en) 2003-03-26
EA199800352A1 (en) 1998-12-24
NO981387D0 (en) 1998-03-26
WO1997012041A1 (en) 1997-04-03
NO981387L (en) 1998-05-29
HUP9802699A3 (en) 2000-09-28
HUP9802699A2 (en) 1999-03-29
CZ92198A3 (en) 1998-07-15
KR20030096447A (en) 2003-12-31
NZ320932A (en) 2000-01-28
TR199800575T1 (en) 1998-06-22
EP0859842A4 (en) 1999-02-24
EP0859842A1 (en) 1998-08-26
BG102413A (en) 1999-04-30
AU711573B2 (en) 1999-10-14
BR9610671A (en) 1999-07-06
KR19990063834A (en) 1999-07-26
CN1198186A (en) 1998-11-04
JPH11512610A (en) 1999-11-02
MX9802380A (en) 1998-08-30
AU7379096A (en) 1997-04-17
ZA968204B (en) 1997-04-09

Similar Documents

Publication Publication Date Title
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
GB9513118D0 (en) Therapeutic agents
GB9526560D0 (en) Use of 2-Amino-Heterocycles
GB9503240D0 (en) Preparation
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
IL118294A0 (en) Preparation of 4-aryl-piperidine derivatives
GB9512290D0 (en) Uses of polyhexanide
PL321686A1 (en) Trensdermal preparation
IL122607A0 (en) Preparation of N-substituted 3-hydroxypyrazoles
IL116924A (en) Preparation of n-aryl - and n-hetarylhydroxylamines
IL117668A0 (en) Preparation of polyesters
GB9500580D0 (en) Therapeutic agents
DE59608164D1 (en) Cyclohexenonoximether-metallsalze
SG42329A1 (en) Use of phenylcyclohexylcarboxamides
GB9501865D0 (en) Therapeutic agents
HUP9603529A2 (en) Femoral part of hip-joint-prothesis
ZA968204B (en) Short forms of chemokine beta-8
PL320114A1 (en) Phenyl-substituted fluoroderivatives of 4-azasteroides
PL325170A1 (en) Bipolar forms of throwaflocacin
IL117786A (en) Preparation of alpha-bisoximes
ZA968873B (en) Isomerisation of equillin
HUT76555A (en) Derivatives of trans apovincaminic-acid-esters
NZ295530A (en) Preparation of 1-halo-3-trialkylsilanyl-benzenes
ZA962343B (en) Preparation of cis-4-o-protected-2-cyclopentenol derivatives
ZA962440B (en) Destressing of railtracks